pyrroles has been researched along with thiourea in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crippen, GM; Ghose, AK | 1 |
| Dienstbier, Z; Kozák, I; Kronrád, L | 1 |
| Guilford, H; Scott, JE | 1 |
| Soós, T; Vakulya, B; Varga, S | 1 |
| Ballard, TE; Cavanagh, J; Mathies, LD; Melander, C; Reyes, S; Richards, JJ; Stowe, SD; Tucker, AT | 1 |
| Cheng, JP; Li, X; Luo, S | 1 |
| Dagousset, G; Masson, G; Retailleau, P; Zhu, J | 1 |
| Aminabhavi, TM; Dixit, SR; Joshi, SD; Kirankumar, MN; Lherbet, C; Narayan, R; Raju, KV; Yang, KS | 1 |
| Fujioka, Y; Fujita, H; Gomori, A; Harada, N; Haruma, T; Hashimoto, A; Inada, M; Ito, K; Kataoka, Y; Matsuo, K; Oda, N; Sakuragi, M; Suzuki, T; Tanaka, K; Yamamoto-Yokoi, H; Yonekura, K | 1 |
9 other study(ies) available for pyrroles and thiourea
| Article | Year |
|---|---|
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
Topics: Binding Sites; Escherichia coli; Folic Acid Antagonists; Models, Molecular; Protein Conformation; Structure-Activity Relationship | 1985 |
Distribution and behaviour of isoselenouronium salts in the body. IV. 2-Aminoselenoazoline.
Topics: Animals; Dose-Response Relationship, Drug; Isothiuronium; Kinetics; Male; Mice; Organoselenium Compounds; Pyrroles; Radiation-Protective Agents; Radioisotopes; Rats; Selenium; Thiourea | 1975 |
Alcian blue 8GX. Investigation of structural details using nuclear magnetic resonance and mass spectrometry.
Topics: Coloring Agents; Copper; Deuterium; Dioxins; Magnetic Resonance Spectroscopy; Mass Spectrometry; Methylation; Nitriles; Pyrroles; Staining and Labeling; Thiourea; Urea | 1972 |
Epi-cinchona based thiourea organocatalyst family as an efficient asymmetric Michael addition promoter: enantioselective conjugate addition of nitroalkanes to chalcones and alpha,beta-unsaturated N-acylpyrroles.
Topics: Acids; Acylation; Alkanes; Amines; Catalysis; Chalcone; Cinchona; Methane; Molecular Structure; Nitro Compounds; Pyrroles; Rolipram; Stereoisomerism; Thiourea | 2008 |
Amide isosteres of oroidin: assessment of antibiofilm activity and C. elegans toxicity.
Topics: Amides; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Pseudomonas aeruginosa; Pyrroles; Structure-Activity Relationship; Sulfonamides; Thiourea; Urea | 2009 |
Asymmetric conjugate addition of oxindoles to 2-chloroacrylonitrile: a highly effective organocatalytic strategy for simultaneous construction of 1,3-nonadjacent stereocenters leading to chiral pyrroloindolines.
Topics: Acrylonitrile; Catalysis; Combinatorial Chemistry Techniques; Hydrocarbons, Chlorinated; Indole Alkaloids; Indoles; Oxindoles; Pyrroles; Stereoisomerism; Thiourea | 2010 |
Chiral phosphoric acid-catalyzed enantioselective three-component Povarov reaction using cyclic enethioureas as dienophiles: stereocontrolled access to enantioenriched hexahydropyrroloquinolines.
Topics: Aldehydes; Aniline Compounds; Bignoniaceae; Catalysis; Combinatorial Chemistry Techniques; Molecular Structure; Phosphoric Acids; Pyrroles; Quinolines; RNA, Plant; Stereoisomerism; Thiourea | 2012 |
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Humans; Isoxazoles; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrroles; Staphylococcus aureus; Thiourea | 2016 |
High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.
Topics: A549 Cells; Animals; Bone Neoplasms; Cell Differentiation; Cell Proliferation; Crizotinib; Disease Models, Animal; Humans; Indoles; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Osteoclasts; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Pyrroles; Quinolines; RANK Ligand; Receptor, Macrophage Colony-Stimulating Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sunitinib; Thiourea; Tibia; Transplantation, Heterologous; X-Ray Microtomography | 2016 |